Identity and synonyms
Keep reduced/oxidized forms distinct; do not classify glutathione alongside NAD as non-peptide.
Synonyms: GSH · GSSG (oxidized form)
Peptide or peptide-related · Peptide or peptide derivative
Detailed molecular class: Tripeptide; not non-peptidic
Supplied sequence or chemical reference
PubChem CID: 124886
Molecular formula: C10H17N3O6S
IUPAC: (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
Source: PC-GLUTATHIONE
Database chemical reference; does not certify supplier vial, salt, isomer or formulation.
Mechanism
Cellular redox chemistry.
Evidence and critical reading
Reported scientific and empirical uses
Skin, hair and cosmetics
Antioxidant tripeptide offered orally, topically and IV for skin or “detox”.
Human evidence
Small oral/topical skin studies do not validate IV detoxification or systemic anti-aging claims.
Preclinical evidence
Antioxidant mechanisms do not establish a clinically useful “detox” endpoint.
Critical reading and limitations
A twelve-week oral trial assessed skin; it does not validate infusions, universal lightening or general clinical detoxification.
Evidence applies to the exact molecule, formulation, route, population and endpoint studied. Supplier identity, purity and clinical equivalence are unverified.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
Listed regimens preserve source/context. An empty layer means no regimen attributable to this identity was verified in this review; it does not prove universal absence of data.
Human-study exposure
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
Reported by Glutathione and its antiaging and antimelanogenic effects.
250 mg · Total daily amount
- Frequency
- Daily
- Duration
- 12 weeks
- Route
- Oral
- Context
- Separate GSH/GSSG arms; not a whitening infusion or blend.
- Presentation
- A dosage-form presentation is not specified in the reviewed record.
- Interpretation
- Research exposure: not a prescription or starting regimen. It does not reconstruct protocol titration, exclusions or monitoring.
PMID28490897 · October 16, 2026
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
Empirical handbook
Listed regimens preserve source/context. An empty layer means no regimen attributable to this identity was verified in this review; it does not prove universal absence of data.
Regulation and safety
Jurisdiction-specific regulatory context
Jurisdiction-specific approval not verified in this card; do not infer global nonapproval.
Adverse effects and unknowns
Safety is formulation/route-specific; supplement observations cannot establish IV safety or stack compatibility.
Reduced/oxidized form, route, excipients and sterility change exposure/risks.
Contraindications
See supported safety statements and exact product label; a complete contraindication set has not been established for this catalog material.
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Only explicitly cited interactions may be asserted; unstudied combinations remain unknown, not interaction-free.
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Glutathione · 272 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07833865 · The Effect of Light Therapy on Cellular Energy and Oxidative Stress in Healthy Adults and Type 1 Diabetic PatientsRegistry status: Not yet recruitingLast update posted: October 16, 2026Query verification: October 16, 2026
NCT07873281 · Expanded Access Protocol for SPI-1005Registry status: Temporarily not availableLast update posted: October 14, 2026Query verification: October 16, 2026
NCT06620523 · Prevent Cardiac Surgery Associated AKI TrialRegistry status: RecruitingLast update posted: October 14, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- PC-GLUTATHIONE
PubChem glutathione (CID 124886)
October 16, 2026
- PMID28490897
Glutathione and its antiaging and antimelanogenic effects.
Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P.
October 16, 2026
- pdf01
PEPNEXA 2.pdf
October 16, 2026
- pdf02
ELLA PEPTIDES.pdf
October 16, 2026
- pdf03
zlz list 26.8.5.pdf
October 16, 2026
- pdf05
PEPNEXA.pdf
October 16, 2026
- pdf07
US Peptide MangerCorp(1).pdf
October 16, 2026
- pdf09
PeptideFactory.pdf
October 16, 2026